Sveriges mest populära poddar
TechCrunch Startup News
NyheterTeknologi

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation; plus, Passionfroot raises $15M to expand its B2B creator marketplace to the US

7 min•23 juli 2026

Colossal Biosciences is in talks to raise new funding at a $20 billion to $30 billion valuation, Axios reported.

Also, Passionfroot, a German startup building a marketplace connecting B2B creators with brands, has raised $15M in a Series A round led by Insight Partners.

Learn more about your ad choices. Visit podcastchoices.com/adchoices

Fler avsnitt av TechCrunch Startup News

Visa alla avsnitt av TechCrunch Startup News
AI isn’t close to curing cancer. Vivodyne says it knows what it will take; plus, TerraPower’s nuclear reactor has a secret weapon for powering AI data centers
•11 min
DOJ’s probe into Andreessen Horowitz over board seats baffles VCs; plus, Etched’s valuation doubles to $21B in a month
•7 min
Sound-powered fire protection startup gets $15M to snuff out fires before they turn catastrophic; plus, Wispr looks beyond dictation
•7 min
SpaceX officially closes its Cursor acquisition; plus, Stripe will reportedly acquire AI gateway startup OpenRouter for $7B+
•3 min
How a $250 million acquisition collapsed into allegations of fraud and forged signatures
•7 min
Reservoir raises $8M to make water heaters that people and the grid will actually want; plus, AI code-testing startup Blacksmith’s valuation jumps almost 10x
•9 min
Tech industry is buzzing after a Claude agent hacked into a gym; plus, Kyoto Fusioneering starts work on key fusion power plant device
•10 min
Discovered Materials is playing AI whack-a-mole to hunt cooler chips
•6 min
This former notorious red-light district is now one of the world’s top AI hubs
•8 min
Naïve automates the grunt work of setting up and running a company, plus, Defense tech Hadrian raises $1.37B, and Omilia raises $67M to scale its customer support platform
•12 min

TechCrunch Startup News med TechCrunch finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.